Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kymera Therapeutics (KYMR) Cash from Operations (2019 - 2026)

Kymera Therapeutics (KYMR) has disclosed Cash from Operations for 8 consecutive years, with 88840000.0 as the latest value for Q1 2026.

  • For Q1 2026, Cash from Operations fell 12.24% year-over-year to 88840000.0; the TTM value through Mar 2026 reached 242581000.0, down 3.64%, while the annual FY2025 figure was 232891000.0, 19.74% down from the prior year.
  • Cash from Operations hit 88840000.0 in Q1 2026 for Kymera Therapeutics, down from 66747000.0 in the prior quarter.
  • Across five years, Cash from Operations topped out at 8045000.0 in Q4 2023 and bottomed at 88840000.0 in Q1 2026.
  • Average Cash from Operations over 5 years is 45420176.47, with a median of 40295000.0 recorded in 2022.
  • Year-over-year, Cash from Operations soared 120.35% in 2023 and then tumbled 867.98% in 2024.
  • Kymera Therapeutics' Cash from Operations stood at 39536000.0 in 2022, then skyrocketed by 120.35% to 8045000.0 in 2023, then crashed by 867.98% to 61784000.0 in 2024, then fell by 8.03% to 66747000.0 in 2025, then tumbled by 33.1% to 88840000.0 in 2026.
  • According to Business Quant data, Cash from Operations over the past three periods came in at 88840000.0, 66747000.0, and 27110000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.